EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement

30 September 2019

Brussels, 30 September 2019 – Amidst discussions on the International […]

Christoph Stoller (Teva) Appointed as new President of Medicines for Europe
Immediately calls on new President of EU Commission to prioritise Healthcare

25 September 2019

Christoph Stoller was elected as President of Medicines for Europe […]

A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector

24 September 2019

The value added medicines sector group of Medicines for Europe […]

Ready to drive access to medicines

21 June 2019

Medicines for Europe is ready to engage with the EU […]

Committing to Global Health: Balancing Access and Sustainability key to success

13 June 2019

Global medicine manufacturers gathered in Warsaw this week to discuss […]

Huge European Parliament majority votes to adopt the SPC manufacturing waiver

17 April 2019

The European Parliament today voted overwhelmingly with 572 Members of […]

‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access

3 April 2019

Medicines for Europe has launched its vision for pharmaceutical policy […]

Major challenges in the Intellectual Property (IP) environment for pharmaceuticals debated at Medicines for Europe Legal Conference

27 March 2019

The SPC manufacturing waiver, which will put an end to […]

Joint Press Statement of the Inter Associations Initiative (IAI) Pharmaceuticals in the Environment Task Force (AESGP, EFPIA, Medicines for Europe) – European Union Strategic Approach to Pharmaceuticals in the Environment

12 March 2019

Report calls for better environment to improve patient access to value added medicines

26 February 2019

A new report launched today lays out clear recommendations to […]